A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients.

scientific article published on 9 December 2015

A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/LEU.2015.333
P698PubMed publication ID26648537

P50authorFrancesca Romana MauroQ51820083
Neil E KayQ54295335
Giovanna CutronaQ54323503
Agostino CortelezziQ56461136
Antonino NeriQ56850455
Massimo FedericoQ57031724
Tait D ShanafeltQ89771809
Anna Grazia RecchiaQ37837458
Katia TodoertiQ39052018
Manlio FerrariniQ42322785
P2093author name stringF Di Raimondo
I Alvarez
G Longo
C Musolino
E Vigna
F Morabito
N Di Renzo
M Gentile
G Tripepi
F Angrilli
S Fabris
S Molica
I Vincelli
S Matis
L Levato
S Zupo
G Festini
U Consoli
A Arcari
D Mannina
P2860cites workProspective validation of a risk score based on biological markers for predicting progression free survival in Binet stage A chronic lymphocytic leukemia patients: Results of the multicenter O-CLL1-GISL studyQ60596975
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelinesQ24616084
Genomic aberrations and survival in chronic lymphocytic leukemiaQ28141442
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemiaQ28394721
Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemiaQ33873337
Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.Q33873343
National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatmentQ34382878
Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemiaQ34418874
CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potentialQ35769292
Multivariable model for time to first treatment in patients with chronic lymphocytic leukemiaQ36925185
Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemiaQ44904842
Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemiaQ47812640
The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia.Q51518841
P433issue6
P921main subjectlymphocyteQ715347
chronic lymphocytic leukemiaQ1088156
P304page(s)1440-1443
P577publication date2015-12-09
P1433published inLeukemiaQ6534498
P1476titleA progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients
P478volume30

Reverse relations

cites work (P2860)
Q48736600Assessing time to first treatment in early chronic lymphocytic leukemia (CLL): a comparative performance analysis of five prognostic models with inclusion of CLL-international prognostic index (CLL-IPI).
Q41694305Long non-coding RNAs in B-cell malignancies: a comprehensive overview.
Q50852727Predicting time to first treatment in early stage CLL: scores, values and comparative prognostic models.
Q48191093Reliability of six prognostic models to predict time-to-first-treatment in patients with chronic lymphocytic leukaemia in early phase.
Q50532164Subtype assignment of CLL based on B-cell subset associated gene signatures from normal bone marrow - A proof of concept study.
Q42711562The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients.
Q38822886lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome

Search more.